Latest News - Stryker Corporation
Top Corporates Hub
Stryker Corporation
J&J's MedTech Segment Eyes Another Strong Quarter in Q2
06.07.2026 14:58
JNJ's Q2 MedTech results will test whether cardiovascular, surgery and vision strength can offset ongoing China VBP headwinds and sustain growth.
Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income
06.07.2026 10:50
When searching for dividend stocks, avoid high-yield traps. Stryker (SYK) offers a sustainable 1.08% yield with strong 7.89% annual growth, solid profitability, and a healthy payout ratio.
Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income
06.07.2026 10:50
When searching for dividend stocks, avoid high-yield traps. Stryker (SYK) offers a sustainable 1.08% yield with strong 7.89% annual growth, solid profitability, and a healthy payout ratio.
Stryker: The Reshaped Product Portfolio Will Drive Growth
02.07.2026 05:25
Stryker looks undervalued after a cyber incident, with 32 years of dividend hikes, strong cash flow and M&A growth. Learn more on SYK stock here.
Stryker to announce second quarter 2026 financial results
01.07.2026 12:00
Portage, Michigan, July 01, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) will host a webcast at 4:30 p.m. (Eastern time) on Thursday, July 30, 2026, to discuss its second quarter 2026 financial results. The live webcast can be accessed at Stryker - Events & Presentations. An archive of the webcast will also be available at Stryker’s website beginning approximately two hours after the live call ends. An accompanying press release that includes summary financial information for the second quarter
Stryker (SYK) Stock Weighs DCF Upside Against High P/E After Recent Price Rebound
30.06.2026 12:07
If you are wondering whether Stryker stock is offering fair value or a potential opportunity right now, the key is understanding what the current price is actually reflecting. The stock last closed at US$330.52, with returns of 8.5% over the past week and 8.3% over the past month, while the return year to date is down 5.1% and the return over the past year is down 15.6%. Recent headlines around Stryker have kept the stock on many investors' watchlists, as the company continues to sit at the...
Stryker (SYK) Is Up 8.5% After Broad Russell Growth Index Removal Reshapes Its Shareholder Base
30.06.2026 10:07
On 27 June 2026, Stryker Corporation was removed from multiple Russell growth indexes, including the Russell 1000 Growth, Russell 3000 Growth, Russell Top 200 Growth, and Russell 3000E Growth benchmarks. This broad index removal matters because it can trigger compulsory selling by index-tracking funds, reshaping who owns Stryker shares and how they trade. Next, we’ll examine how Stryker’s removal from several Russell growth benchmarks could influence its existing investment narrative and...
Leerink Sees Attractive Risk-Reward in Stryker (SYK) Despite First-Quarter Revenue Miss
26.06.2026 11:11
Stryker Corporation (NYSE:SYK) ranks among the best set-it-and-forget-it stocks to buy right now. On June 5, Leerink reduced its price target for Stryker Corporation (NYSE:SYK) to $407 from $410 while keeping an Outperform rating on the company’s stock. The firm changed its SYK model in response to new 10-Q filings following the company’s first-quarter 2026 […]
What Makes Stryker Corp. (SYK) One of the Best Robotics and Automation Stocks
25.06.2026 06:02
Stryker Corp. (NYSE:SYK) is one of the 10 best robotics and automation stocks to invest in. On May 26, Stryker Corp. (NYSE:SYK) introduced its Pangea Plating System to the European market. This hardware platform is built to treat many different types of bone fracture patterns. Orthopedic trauma surgeon at St. George’s University Hospital in London, […]
BofA Cuts Stryker (SYK) Target; Is a Medtech Slowdown Starting to Show?
22.06.2026 13:10
With a short percentage of shares outstanding of 1.63%, Stryker Corporation (NYSE:SYK) is among the 7 Best Longevity and Anti-Aging Stocks to Buy. On June 12, BofA lowered its price target on Stryker Corporation (NYSE:SYK) to $380 from $450 while maintaining a Buy rating on the shares. The firm cited a softer healthcare utilization environment highlighted by its services team and […]
3 of Wall Street’s Favorite Stocks to Consider Right Now
22.06.2026 12:51
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
Stryker Corp (NYSE:SYK): A Top-Tier Dividend Growth Stock Built on Profitability and Financial Health
13.06.2026 10:10
Stryker offers a modest 1.17% yield with exceptional dividend safety and growth. Strong profitability and reasonable valuation make NYSE:SYK a quality dividend growth stock for long-term investors.
Stryker (SYK) Stock After 16.5% One-Year Slide Is The Market Overreacting
13.06.2026 09:11
Wondering if Stryker at around US$312.20 is offering value or just pricing in high expectations already? This article breaks down what the current share price might be implying. The stock is up 2.1% over the past week and 3.3% over the past month, yet is still down 10.3% year to date and has declined 16.5% over the past year, which may have some investors questioning whether recent weakness reflects risk or creates an opening. Recent news around Stryker has focused on its role in the medical...
Stryker Weighs Cyber Setback Against Robotics Strength And Global Growth
13.06.2026 06:09
Stryker (NYSE:SYK) reported that an early-2026 cyber incident disrupted parts of its operations but did not derail overall demand. The company highlighted record Mako robotics installations and broader use cases across orthopedic procedures. International markets contributed more to growth, supported by new product approvals and expanding global adoption. Stryker, trading around $312.2, has seen mixed share performance, with the stock down 10.3% year to date and down 16.5% over the past...
Stryker’s Pangea Europe Launch And What It Means For NYSE SYK Investors
10.06.2026 02:11
Stryker (NYSE:SYK) has introduced its Pangea Plating System trauma platform to the European market. The launch marks an extension of a product line that was previously available in North America. The system is designed to support fracture fixation and deepen collaboration with orthopedic surgeons in Europe. Stryker operates at the intersection of medical devices and orthopedics, where trauma implants are a core part of the business. Bringing the Pangea Plating System to Europe adds another...
Medtronic: The Turnaround Is Quietly Working
06.06.2026 04:30
Medtronic (MDT) outlook: mid-single-digit growth, stabilizing margins, and new drivers (Hugo, Affera). Read here for a detailed analysis.
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
05.06.2026 15:30
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Stryker Unveils TPX HD As Stock Trades Below Analyst Targets
04.06.2026 08:15
Stryker (NYSE:SYK) has introduced TPX HD, a next-generation surgical power tool for demanding orthopedic procedures. The system is designed to offer higher torque, customizable control, and improved ergonomics for revision and minimally invasive surgeries. This launch adds a new product to Stryker's existing orthopedic portfolio and follows earlier product and cybersecurity updates. Stryker's new TPX HD system arrives as the stock trades at around $295.0, with the share price down 15.3%...
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
02.06.2026 14:29
Globus Medical is riding musculoskeletal market growth with spine, trauma and ortho gains, strong cash flow and a debt-free balance sheet.
Stryker launches TPX HD® power tool, supporting demanding orthopaedic procedures
02.06.2026 13:03
Stryker (NYSE: SYK), a global leader in medical technologies, announced the launch of its TPX HD, a premium small bone power tool designed to support performance, control and ergonomics in a wide range of challenging orthopaedic procedures such as total joint revisions, minimally invasive surgery and oral maxillofacial procedures.